Invesco Ltd. Stock
Invesco Ltd. Stock
There is an upward development for Invesco Ltd. compared to yesterday, with an increase of €0.46 (1.880%).
With 20 Buy predictions and not the single Sell prediction the community is currently very high on Invesco Ltd..
As a result the target price of 26 € shows a slightly positive potential of 4.04% compared to the current price of 24.99 € for Invesco Ltd..
For the coming years our community has positive and negative things to say abot the Invesco Ltd. stock. Criterium "EBIT growth" gathered the most positive votes but regarding "Management" there were negative voices in the community.
Pros and Cons of Invesco Ltd. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Invesco Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Invesco Ltd. | 1.880% | -8.230% | 6.791% | 30.409% | 6.053% | 62.882% | 19.717% |
| Federated Investors Inc. | -0.950% | 5.000% | 2.941% | 25.598% | 15.639% | 61.043% | 93.015% |
| Ares Management L.P | -0.180% | 6.839% | 18.402% | -31.143% | -21.724% | 24.222% | 93.286% |
| Affiliated Managers Group | -3.090% | 8.725% | 8.000% | 78.022% | 31.707% | 161.290% | 147.328% |
sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2025-04-29
Invesco Ltd. (IVZ) demonstrates a stable financial position with some positive trends in its latest quarterly report (Q2 2025). Key findings include:
The overall financial trend appears positive, driven by revenue growth and improved profitability.
The company shows improving profitability due to better cost management and revenue growth.
Comments
Invesco (IVZ) had its price target raised by Royal Bank Of Canada from $33.00 to $35.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for IVZ provided by MarketBeat
Invesco (IVZ) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Show more
Ratings data for IVZ provided by MarketBeat
Invesco (IVZ) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $31.00 price target on the stock.
Show more
Ratings data for IVZ provided by MarketBeat
News
VHT vs. PBE: Which Health Care ETF Is the Better Buy?
The Invesco Biotechnology & Genome ETF (NYSEMKT:PBE) offers a focused, high-momentum approach to the biotechnology sector, while the Vanguard Health Care ETF (NYSEMKT:VHT) provides broad, low-cost
Invesco Q2 Earnings Call Highlights
Key Points
- Interested in Invesco Ltd.? Here are five stocks we like better.
- Invesco reported record growth in the second quarter, with $45.1 billion in net long-term inflows, assets under
Better Healthcare Sector ETF: Vanguard's Broad VHT vs. Invesco's Biotechnology-Focused IBBQ
The Vanguard Health Care ETF (NYSEMKT:VHT) offers broad sector exposure and lower costs, while the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) provides a concentrated, higher-volatility play on